The PLA2G6 gene in early-onset Parkinson's disease

Movement Disorders

Volumn 26, Issue 13, 2011, Pages 2415-2417

  Kauther, Kai Michael ^a   Höft, Christine ^a   Rissling, Ida ^a   Oertel, Wolfgang H ^a   Möller, Jens Carsten ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

Genetics; NBIA; PARK14; Parkinson syndrome; SNP

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; EXON; FEMALE; GENE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOGENESIS; PLA2G6 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CALCIUM; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GROUP VI PHOSPHOLIPASES A2; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 81955160792     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23851     Document Type: Article

References (19)

1. Rhodes SL, Ritz B. Genetics of iron regulation and the possible role of iron in Parkinson's disease. Neurobiol Dis. 2008; 32: 183-195.
2. Tsang AH, Chung KK. Oxidative and nitrosative stress in Parkinson's disease. Biochim Biophys Acta. 2009; 1792: 643-650.
3. Adibhatla RM, Hatcher JF. Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies. BMB Rep. 2008; 41: 560-567.
4. Morgan NV, Westaway SK, Morton JE, et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet. 2006; 38: 752-754.
5. Kurian MA, Morgan NV, MacPherson L, et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology. 2008; 70: 1623-1629.
6. Paisan-Ruiz C, Bhatia KP, Li A, et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol. 2009; 65: 19-23.
7. Paisan-Ruiz C, Guevara R, Federoff M, et al. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord. 2010; 25: 1791-1800.
8. Sina F, Shojaee S, Elahi E, Paisan-Ruiz C. R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family. Eur J Neurol. 2009; 16: 101-104.
9. Yoshino H, Tomiyama H, Tachibana N, et al. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism. Neurology. 2010; 75: 1356-1361.
10. Tan EK, Ho P, Tan L, et al. PLA2G6 mutations and Parkinson's disease. Ann Neurol. 2010; 67: 148.
11. Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol. 2006; 5: 355-363.
12. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998; 392: 605-608.
13. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004; 304: 1158-1160.
14. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003; 299: 256-259.
15. Möller JC, Leinweber B, Rissling I, et al. Prevalence of the H1069Q mutation in ATP7B in discordant pairs with early-onset Parkinson's disease. Mov Disord. 2006; 10: 1789-1792.
16. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55: 181-184.
17. BLAST. .
18. Moore DJ, West AB, Dawson VL, Dawson TM. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci. 2005; 28: 57-87.
19. Kahle PJ, Waak J, Gasser T. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Free Radic Biol Med. 2009; 47: 1354-1361.